Search

everythinglearnresearchcommunity

for

Search:↓

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Finasteride increases CD8+ T cells in BPH tissues.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

The effectiveness of platelet-rich plasma for erectile dysfunction is still unclear.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

Androgen, especially DHT, is crucial for erectile function in rats by affecting specific brain neurons.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Men with self-diagnosed PFS-related ED have normal erectile hemodynamics.

DPP may help hair regrowth by improving blood vessel function under stress.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Four-amino acid part makes enzyme sensitive to finasteride.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

Finasteride may affect male fertility by interfering with specific sperm signaling.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.